Interplay between cancer cells, macrophages and natural killer cells may actually decide the outcome of therapy with sorafenib.

Abstract

1 Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 2 Department of Hematology, Ion Chiricuta Comprehensive Cancer Center, Cluj Napoca, Romania. 3 Department of Internal Medicine, Immunology and Infectious Diseases, Section of Internal Medicine, University of Bari Medical… (More)
DOI: 10.1002/hep.26907

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics